The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Docetaxel 20mg/ml concentrate for solution for infusion

Seacross Pharma (Europe) LimitedPA22766/001/001

Main Information

Trade NameDocetaxel 20mg/ml concentrate for solution for infusion
Active SubstancesDocetaxel anhydrous
Dosage FormConcentrate for solution for infusion
Licence HolderSeacross Pharma (Europe) Limited
Licence NumberPA22766/001/001

Group Information

ATC CodeL01CD Taxanes
L01CD02 docetaxel


License statusAuthorised
Licence Issued26/08/2011
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back